Skip to main content

Broderick Brian C

SEC CIK
0001314376
Latest filing
Aug 10, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Broderick Brian C, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
5,065
Value
$242.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Broderick Brian C, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,065$242.8K<0.1%−480−8.7%ReducedHolders
Q1 20265,545$203.8K<0.1%−590−9.6%ReducedHolders
Q4 20256,135$312.1K0.1%−29,866−83.0%ReducedHolders
Q3 202536,001$2.00M0.4%−5,060−12.3%ReducedHolders
Q2 202541,061$2.83M0.6%+8,350+25.5%AddedHolders
Q1 202532,711$2.27M0.5%+26,795+452.9%AddedHolders
Q4 20245,916$508.9K0.1%−175−2.9%ReducedHolders
Q3 20246,091$725.3K0.1%−349−5.4%ReducedHolders
Q2 20246,440$919.2K0.2%−355−5.2%ReducedHolders
Q1 20246,795$872.5K0.2%−885−11.5%ReducedHolders
Q4 20237,680$794.5K0.2%−450−5.5%ReducedHolders
Q3 20238,130$739.3K0.2%−490−5.7%ReducedConverted for a 2-for-1 splitHolders
Q2 20234,310$697.5K0.2%−100−2.3%ReducedHolders
Q1 20234,410$701.8K0.2%−125−2.8%ReducedHolders
Q4 20224,535$613.8K0.2%00.0%UnchangedHolders
Q3 20224,535$452.0K0.1%−165−3.5%ReducedHolders
Q2 20224,700$524.0K0.2%−100−2.1%ReducedHolders
Q1 20224,800$533.0K0.1%−185−3.7%ReducedHolders
Q4 20214,985$558.0K0.1%+910+22.3%AddedHolders
Q3 20214,075$391.0K0.1%−200−4.7%ReducedHolders
Q2 20214,275$358.0K0.1%−50−1.2%ReducedHolders
Q1 20214,325$292.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.